惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

L
LangChain Blog
博客园 - 司徒正美
美团技术团队
Martin Fowler
Martin Fowler
雷峰网
雷峰网
aimingoo的专栏
aimingoo的专栏
博客园 - 三生石上(FineUI控件)
Vercel News
Vercel News
酷 壳 – CoolShell
酷 壳 – CoolShell
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
爱范儿
爱范儿
U
Unit 42
Y
Y Combinator Blog
月光博客
月光博客
Hugging Face - Blog
Hugging Face - Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
有赞技术团队
有赞技术团队
GbyAI
GbyAI
H
Help Net Security
量子位
Last Week in AI
Last Week in AI
博客园_首页
腾讯CDC
小众软件
小众软件

JPost.com - Business & Innovation | The Jerusalem Post

Your Investments: Financial freedom and Jerusalem unification Your Taxes: How Israel’s new war compensation system works Victory for the Negev vision: Light Rail will reach gates of the intelligence campus - opinion Only 45% of Tel Aviv Stock Exchange companies made donations in 2025, study finds “Within 5 to 6 Years, all of Israel will be connected to a single water network” Forget the model wars, the real AI challenge is orchestration -opinion Israeli-Cypriot cyber company to unveil Starlink de-anonymizing tool - report Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy Israel’s inflation dynamics remain under control IDF reservists created 150 new startups during last year, innovation program reveals Trump to regulate AI development after Anthropic's Mythos posed cybersecurity threat - report Your Investments: Prosperity in Israel takes time, but aliyah is worth it Your Taxes: An agreement is an agreement Inside Inspiraction, the Jerusalem incubator helping young Israelis turn ideas into start-ups Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration The death of the US Jewish Orthodox middle class- opinion Real estate giant invests $200 million into Miami’s high-tech hub: What’s Flow Wynwood? Almost half of operational decisions will be done by AI in 2030, IBM reveals - poll It’s all about timing! 2026 is a rare opportunity window for Tel Aviv real estate A new standard of hospitality How Israel’s new reporting rules change the olim tax holiday - opinion Senior R&D managers are paying the price of the AI revolution - opinion Consumer guilt costs companies billions in abandoned online shopping carts - study A strategic miss: R&D is Israel's brain - so why does it develop, manufacture abroad? - opinion Connecting neighbors under fire: The story behind Angels of the Shelter AI is ending era of ‘job immunity’ for young tech workers as it reshapes Israel's job market Israeli AI startup cracks code of who is at fault when system fails: What do they do? - interview Your Taxes: Israel’s lower mid-market is tempting international M&A buyers Your Investments: Second chances, respect, and newlywed finance Microbes coordinate activity to reduce competition, Israeli researchers discover
Seph Fontane Pennock turned patient frustration into entr...
IN COOPERATION WITH TOM WHITE · 2026-06-15 · via JPost.com - Business & Innovation | The Jerusalem Post
ByIN COOPERATION WITH TOM WHITE

For years, Seph Fontane Pennock sat inside a $16 billion industry as a patient. Zero outside scrutiny. Mold illness sent him country to country, through more than fifteen regenerative medicine clinics, trying whatever worked and cutting his losses on what didn't. Along the way, what he saw frustrated him every bit as much as the mold illness itself. A booming industry with no independent accountability, no way for patients to separate credible providers from convincing ones, and no one checking.

Some clinics were already on federal exclusion lists, flagged by government agencies, and still open for business. Some providers listed treatments they couldn't actually deliver. Serious procedures happening inside IV bars, not a physician in sight.

So Seph Fontane Pennock built Regenerated. His vetted directory of regenerative medicine clinics launched in May 2026 with over 8,000 listings across all fifty US states, pulled from a review of more than 20,000 providers.

"There's a regulatory vacuum in regenerative medicine," he says, "and patients are the ones paying the price. When there's no oversight, the space fills up with both brilliant practitioners and bad actors, and patients have no way to tell the difference."

Regenerated.com goes at that problem directly. Every treatment on his platform carries an evidence rating: strong, emerging, experimental, or insufficient. His team cross-references every clinic against the federal National Provider Identifier registry and the OIG exclusion list. Physician oversight is flagged on every listing. "We're not a regulatory body and we don't pretend to be," Seph Fontane Pennock says. "But we do believe in evidence-based transparency. We show patients what's proven and what's still being studied."

What makes his frustration credible is his track record. Seph Fontane Pennock isn't some first-time founder taking a swing at a big industry. He is a serial builder with a decade of platform development behind him, and a clear method that has worked more than once.

.
. (credit: Zagnore)

There's a version of him most people don't know about. Before any of it, he was a freelancer. SEO work, conversion optimization, online marketing for other people's businesses. Teaching himself everything formal education wasn't giving him. "I have a bachelor's degree in international business," he says, "but I always believed more in self-education. Even before massive open online courses existed, I would find ways to access university-level materials and follow along on my own."

That self-taught foundation built PositivePsychology.com, his first major platform. He started it after following Tal Ben-Shahar's Harvard positive psychology course on his own and finding almost nothing online for the field. Two years of traffic building, a community of unpaid contributors, Facebook groups where he asked people directly what they needed. Then the Positive Psychology Toolkit, a database of science-based interventions for therapists. "We did an email launch to the audience we'd built," he says, "and it generated 70K in annual recurring revenue from just a few emails. That was the moment. We looked at each other and knew we had a real business."

He quit freelancing in 2017. His co-founder Hugo Alberts joined him full-time in 2018, leaving a ten-year professorship at Maastricht University. Their partnership had a clear internal logic. "Hugo and I have always been one plus one equals eleven. He's detail-oriented. I'm not. I'm big-picture, move fast, break things. He kept the quality high while I kept pushing the growth."

COVID accelerated everything. PositivePsychology.com nearly tripled that year. So did Quenza, the digital platform he co-founded with Hugo Alberts and Ernst Jansen that gives therapists and coaches tools to engage clients between sessions through care pathways, assessments, and exercises. When the world moved online, both platforms were already there. 

By May 2023, Fontane Pennock and Alberts sat in a Rockefeller Center conference room and closed an eight-figure sale of PositivePsychology.com to Eden Capital, a New York private equity firm. Quenza was not part of that sale and continues operating today. "Two small-town boys from the Netherlands who started a blog in a Facebook group," he says, "and now we're selling a business accredited by the American Psychological Association to a PE firm in Manhattan."

The exit came with lessons he passes on freely. Work with good lawyers and pay for them. The closing itself is rarely where founders get caught. "My real advice: get 100% clarity on what is expected of you after the sale. We had tax liabilities to clean up post-close that took far longer and cost far more than anyone told us to expect. We grossly underestimated it. That's the thing that catches you off guard, not the deal itself, but the tail end."

It also came with grief. "There's a sense of loss. All the things people warn you about turned out to be true. You miss the team. You miss having something to build. PositivePsychology.com was part of my identity for years. People would recognize me at conferences. We had 650,000 people on our mailing list. Letting that go is harder than you'd expect."

Ten years from now, Seph Fontane Pennock wants one thing said about him. "That he was courageous. That he put a platform out there that went against some of the big interests of the pharmaceutical industry and the way traditional medicine is still being done."

This article was written in cooperation with Tom White

Follow us on Google